crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in … the US pharmaceutical industry. We estimate the effect of patent length and scope on generic entry prior to the expiration … of new drug patents using two quasi-experimental approaches: one based on changes in patent laws and another on the …

This chapter describes the market for pharmaceuticals, which exceeded $500 million in sales in 2010. The industry is … the application of biotechnology to drug development as well as firms that specialize in low-cost production of off-patent … research and incentives for innovation. We then summarize the pricing and marketing of drugs in the US and several other …

supplemental information on IP litigation and patent portfolios. The rich survey information regarding firms’ general innovation …We contribute to the economic literature on patent litigation by taking a new perspective. In the past, scholars mostly … focused on specific litigation cases at the patent level and related technological characteristics to the event of litigation …

intellectual property rights and of offshoring costs on the rate of innovation and on the offshoring intensity. In chapter 4 I …' successful patent applications. The last chapter describes sector-level input-output relationships in eleven European economies …